Kevin L. Hall

Molecular Profiling of Endometrial Malignancies

Norasate Samarnthai, Kevin L. Hall, I‐Tien Yeh · Obstetrics and Gynecology International · 2010 · 134 citations · Full text

Tumoral Pathology, Type Ii Carcinomas, Medicine +10

Analysis of Ki-ras, p53, and MDM2 Genes in Uterine Leiomyomas and Leiomyosarcomas

Kevin L. Hall, Michael Teneriello, Robert R. Taylor et al. · Gynecologic Oncology · 1997 · 78 citations

Mdm2 Genes, Uterine Leiomyomas, Tumoral Pathology +6

Phase II Evaluation of 24-h Continuous Infusion Topotecan in Recurrent, Potentially Platinum-Sensitive Ovarian Cancer: A Gynecologic Oncology Group Study

Maurie Markman, John A. Blessing, Ronald D. Alvarez et al. · Gynecologic Oncology · 2000 · 35 citations

Phase Ii Evaluation, Medicine, Cancer Management +7

Asian-Pacific Islander race independently predicts poor outcome in patients with endometrial cancer☆☆The views expressed herein are those of the authors and do not reflect the official opinion of the Department of Defense or the United States Army or Air Force.

Edward R. Kost, Kevin L. Hall, Jeffrey F. Hines et al. · Gynecologic Oncology · 2003 · 30 citations

Air Force, Cancer Risk, Cancer Epidemiology +11

Comparative assessment of hypercoagulability in women with and without gynecologic malignancies using the thromboelastograph coagulation analyzer

Mark Wehrum, Jeffrey F. Hines, Edwin B Hayes et al. · Blood Coagulation & Fibrinolysis · 2010 · 19 citations

Gynecology, Pathology, Prolonged Ma Value +21